Table 2 Drug related problems and causes in type 2 diabetes patients with hypertension
Variable category | Frequency (%) |
|---|---|
Number of DRPs | |
One | 64 (21.3) |
Two | 121 (40.3) |
Three | 55 (18.3) |
Four | 6 (2.0) |
Category of DRP and its causes | |
Need for additional drug therapy | 145 (29.4) |
Medical condition requires the initiation of drug therapy | 4 (2.8) |
Preventive drug therapy required to reduce the risk of developing a new condition | 124 (85.5) |
Medical condition requires additional pharmacotherapy to attain synergistic or additive effects | 12 (8.3) |
Required preventive drug therapy to reduce the risk of developing a new condition & a medical condition requires additional pharmacotherapy to attain synergistic or additive effects | 5 (3.4) |
Ineffective drug | 138 (27.9) |
The drug not the most effective for the medical problem | 114 (82.6) |
The drug product is not effective for the indication being treated | 24 (17.4) |
Dosage too low | 78 (15.8) |
The dose is too low to produce the desired response | 76 (97.4) |
Drug interaction reduces the amount of active drug available | 2 (2.6) |
Noncompliance | 60 (12.2) |
The patient prefers not to take the medication | 6 (10.0) |
The patient forgets to take the medication | 27 (45.0) |
The drug product too expensive for the patient | 3 (5.0) |
The patient prefers not to take the medication & the patient forgets to take the medication | 17 (28.3) |
The patient forgets to take the medication & the drug product too expensive for the patient | 5 (8.3) |
The patient prefers not to take the medication, the drug product too expensive for the patient & the patient forgets to take the medication | 2 (3.3) |
Unnecessary drug therapy | 51 (10.3) |
No valid medical indication for the drug | 45 (88.2) |
Multiple drug products are being used for a condition that requires single drug therapy | 4 (7.8) |
No valid medical indication for the drug & multiple drug products are being used for a condition that requires single drug therapy | 2 (3.9) |
Adverse drug reaction | 13 (2.6) |
The drug product causes an undesirable reaction that is not dose-related | 7 (53.9) |
The drug product contraindicated due to risk factors | 6 (46.2) |
Dosage too high | 9 (1.8) |
Dose too high | 7 (77.8) |
A drug interaction occurs resulting in a toxic reaction to the drug product | 2 (22.2) |